CTRI Number |
CTRI/2021/07/035159 [Registered on: 27/07/2021] Trial Registered Prospectively |
Last Modified On: |
05/08/2021 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia Preventive |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
Comparative evaluation of preoperative nebulization with two doses of budesonide for post operative sore throat following endotracheal intubation under general anaesthesia |
Scientific Title of Study
|
Comparative evaluation of preoperative nebulization with two doses of budesonide for post operative sore throat following endotracheal intubation under general anaesthesia |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Ankush Garg |
Designation |
PG Resident |
Affiliation |
Vardhaman Mahavir Medical College and Safdarjung Hospital |
Address |
HOD Anaesthesia office, main OT Complex Ground floor, Safdarjung Hospital, Ansari Nagar East South DELHI 110029 India |
Phone |
01126161960 |
Fax |
01126163072 |
Email |
gargankush27@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Shruti Jain |
Designation |
Consultant |
Affiliation |
Vardhaman Mahavir Medical College and Safdarjung Hospital |
Address |
HOD office Anaesthesia, Main OT complex ground floor safdarjung Hospital, Ansari Nagar East South DELHI 110029 India |
Phone |
9212308441 |
Fax |
01126163072 |
Email |
shruti.anaesth@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Shruti Jain |
Designation |
Professor |
Affiliation |
Vardhaman Mahavir Medical College and Safdarjung Hospital |
Address |
Department of Anaesthesia and Intensive Care, HOD office, Ground floor Main OT Complex safdarjung Hospital, Ansari Nagar East South DELHI 110029 India |
Phone |
9212308441 |
Fax |
01126163072 |
Email |
Shruti.anaesth@gmail.com |
|
Source of Monetary or Material Support
|
Self sponsored |
Vardhaman Mahavir Medical college and Safdarjung Hospital |
|
Primary Sponsor
|
Name |
Ankush Garg |
Address |
Vardhaman Mahavir Medical College and Safdarjung Hospital, Ansari nagar East - 110029 |
Type of Sponsor |
Other [Self sponsored] |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Ankush Garg |
Vardhman Mahavir Medical College and Safdarjung Hospital |
Department of Anaesthesia and Intensive Care, Safdarjung Hospital, Ansari Nagar East South DELHI |
9871281610
gargankush27@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee of Vardhman Mahavir Medical College and Safdarjung Hospital |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis, (2) ICD-10 Condition: N859||Noninflammatory disorder of uterus, unspecified, (3) ICD-10 Condition: K353||Acute appendicitis with localizedperitonitis, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Budesonide |
Preoperative Nebulisation with 250 micrograms of budesonide made to 5ml for 10 minutes, 10 minutes before induction |
Intervention |
Budesonide |
Preoperative nebulisation with 500 microgram of Budesonide made to 5ml for 10 minutes, 10 minutes before induction |
Comparator Agent |
Normal Saline |
Preoperative nebulisation with 5ml of Normal Saline for 10 minutes, 10 minutes before induction |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
Belonging to American society of Anaesthesiologists (ASA) physical status I and II undergoing laparoscopic surgery under general anaesthesia with endotracheal intubation |
|
ExclusionCriteria |
Details |
1)Patients with difficult airway
2)Patients with a history of pre-operative sore throat, oral surgeries, asthma, diabetes, chronic obstructive pulmonary disease, head and neck surgeries.
3)Patient with known allergies to study drug and rescue drugs.
4)Patients consuming non-steroidal anti-inflammatory drugs within 24 hours prior to the surgery or on systemic or topical steroid therapy or having taken steroid drugs within five days prior to the surgery.
5)Duration of surgery > 1 hour and < 4 hours. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Incidence and severity of Postoperative sore throat |
0, 6, 12, 24 hours after extubation |
|
Secondary Outcome
|
Outcome |
TimePoints |
Incidence of cough and hoarseness of voice |
0, 6, 12, 24 hours after extubation |
|
Target Sample Size
|
Total Sample Size="105" Sample Size from India="105"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Post Marketing Surveillance |
Date of First Enrollment (India)
|
29/07/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [gargankush27@gmail.com].
- For how long will this data be available start date provided 15-09-2021 and end date provided 01-09-2022?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
Post-operative
sore throat (POST) is an unavoidable outcome of general anaesthesia following
endotracheal intubation that affects up to 62% of patients undergoing general anaesthesia. It occurs because of aseptic inflammatory process caused by irritation of the
pharyngeal mucosa during laryngoscopy and tracheal mucosa by cuff of
endotracheal tube. It leads to patient’s distress and dissatisfaction.
Complaints of patients include minor throat irritation, inability to swallow,
hoarseness of voice and cough. In most cases it resolves spontaneously without
specific treatment. However, in moderate to severe cases, it may require treatment
for pain and dysphagia.
The
aetiology of POST is multifactorial. It includes patient-related factors such
as age, sex, smoking and intubation
factors including time and manipulations needed to insert the
tube, duration for which the tube is in place, tube size, intra-cuff
pressure, cuff design, intraoperative tube movement and
suctioning.
Various
non-pharmacological and pharmacological methods have been used for attenuating
POST with varying efficacy. The non-pharmacological methods include smaller
size endotracheal tubes, lubricating the endotracheal tube with water soluble
jelly, careful airway instrumentation, intubating after full relaxation, gentle
oesophageal suctioning, minimizing intra-cuff pressure and extubation when the
tracheal cuff is fully deflated. The pharmacological methods
include pre-operative gargling and nebulization with various agents like
ketamine, local anaesthetics, budesonide,
beclomethasone and azulene sulphonate etc. Steroids are well known for their anti-inflammatory
function. They are widely used in clinic. The inhaled corticosteroids (ICSs),
like budesonide and fluticasone, are widely used for patients at risk of airway
diseases (i.e., asthma, chronic obstructive pulmonary disease (COPD) and acute
pharyngitis) due to its high efficacy in controlling and preventing symptom
symptoms with reduced systemic side effects since it can be directly delivered
to the airways without introducing a systemic exposure. The beneficial
properties of ICS include low oral bioavailability, high systemic clearance,
and sufficient receptor binding affinity. Since ICS inhalation possesses these
beneficial properties, it has been considered a more secure treatment. Budesonide
has been used in doses as high as 500 microgram given twice daily (1mg per day)
through nebulized form for 10 consecutive days. It showed no
hypothalamo-pituitary-adrenal-axis suppression. This proves the safety of the
study drug.
Previous
studies have reported different protocols in terms of number of times budesonide
is administered, varying from a single preoperative dosage to multiple
nebulisation
Total
dose of budesonide used in these studies has varied from 200 microgram preoperatively to 1 milligram given in multiple divided doses, but
it has been found that single pre-operative dosage is more efficacious than
multiple nebulisation for preventing POST.
In
this study we aim to compare the efficacy of pre-operative nebulisation with
250 microgram of budesonide versus 500 microgram and normal saline in reduction
of incidence and severity of POST in adult patients following endotracheal
intubation under general anaesthesia undergoing laproscopic surgery. |